Our technology offers an entry into linear peptide drugs and Antibody Drug Conjugates.
Read our latest news and stay updated
EnzyTag to attend the Peptide Therapeutics session of the MipTec conference from September 10-11 2019 in Basel.
Please feel free to contact us
EnzyTag is open to further discussions on technology licensing for commercial purposes.